Rock Health has recently released their Q1 2021 digital health funding report. With $6.7B in US digital health funding Q1 has been the the most-funded quarter to date. Ten years ago, we at Rock Health published our first report on digital health venture investment, highlighting an annual haul of $1.1B from investors into the emerging sector. In each of the last two weeks of…
Ava, a digital healthcare company that focuses on women’s reproductive health, announced today it will be launching the first study of its kind to test whether a wearable device can detect a COVID-19 infection in real-time and alert people to get tested or self-isolate prior to showing symptoms. While other studies to date (including the COVI-GAPP study Ava announced in April 2020) have examined the feasibility of…
Women’s health biotech Celmatix focused uniquely on ovarian biology, today announced that Dr. Adrienne Day has joined the company’s advisory board. Dr. Day joins as the company eyes upcoming nonclinical studies for the lead RSTK agonist program, and continued partnering interest in its category-defining multi-omic ovarian health platform. She will play a key role in supporting the strategic and scientific prioritization of…
Israeli femtech company MobileODT, who are innovating in cervical cancer screening, have announced that their Visual Check AI technology is supporting a large-scale government cervical cancer screening project in the Dominican Republic. This proof of concept project was initiated as part of the company’s strategic direction in providing cervical cancer screening at scale, utilizing Artificial Intelligence (AI) and Machine Learning (ML) capabilities. The…
Merck and Alydia Health have announced that they have entered into a definitive agreement pursuant to which, after the intended Merck spinoff of Organon, Organon will acquire Alydia Health. Alydia Health is a commercial-stage medical device company focused on preventing maternal morbidity and mortality caused by postpartum hemorrhage (PPH) or abnormal postpartum uterine bleeding. PPH is one of the most common complications…
Natera, a global leader in non-invasive genetic testing and analysis of cfDNA, and Tesis Labs, a US multi-region lab services provider with labs in Colorado, Texas and Arizona, announced a strategic partnership in the field of prenatal genetic testing. The collaboration will allow Tesis to broaden its portfolio of genetic testing offerings and participate in the fast growing screening market for over 4 million pregnancies in the…
Neuroscientists and Women’s Brain Project Co-founders Antonella Santuccione Chadha and Maria Teresa Ferretti have recently released their new book Una bambina senza testa, a semi-autobiographical book. The book explores gender difference within the world of mental and neurological diseases and has just been published by Rome-based Edizioni Mondo Nuovo in Italian. Una bambina senza testa is an exciting dialogue between two scientist friends who…
Tia, the modern medical home for women, and CommonSpirit Health, the nation’s largest nonprofit health system, today announced an innovative, first-of-its-kind partnership to create a new front door to healthcare for women. The deal enables the two healthcare leaders to launch Tia-branded women’s health clinics together that will provide comprehensive, blended virtual and in-person care – with plans for the first clinic in Phoenix where…
